|
Martynov A.I., Mazurov V.I., Afanasyev V.V., Bogachev R.S., Bolieva L.Z., Davydkin I.L., Zakharov V.V., Ivanova A.V., Kunyaeva T.A., Leboeva M.M., Levin O.S., Livzan M.A., Malyavin A.G., Mammaev S.N., Tarasova L.V., Trofimov V.I., Trofimov E.A., Chesnikova A.I., Chulkov V.S.
Resolution of the Council of experts “Innovative technologies and perspectives for complex therapy of comorbid conditions in the practice of a therapist”
|
№2 / 2024
|
|
Martynov A.I., Tanashyan M.M., Malyavin A.G., Bogolepova A.N., Borovkova N.Yu., Eliseeva L.N., Zhuravleva M.V., Zakharov V.V., Koryagina N.A., Mikhin V.P., Osipova I.V., Ostroumova O.D., Pozdnyak A.O., Portnyagina U.S., Statsenko M.E., Tyrenko V.V., Chesnikova A.I.
Resolution of the Expert Council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders»
|
№10 / 2023
|
|
Evgenieva A.V., Noskov S.M., Zhomova M.V., Lavrukhina A.A.
Influence of obesity at frailty syndrome manifestations in persons over 75 years old
|
№9 / 2023
|
|
Karpov S.M., Marchenko A.M., Vyshlova I.A., Koichuev A.A., Tambieva Kh.K.-S., Klimenko A.I.
Cognitive disorders in female patients with breast cancer after chemotherapy
|
№5 / 2023
|
|
Kabysh S.S., Prokopenko S.V., Abdullayev M.B.
Cognitive disorders in patients during the acute period of coronavirus infection complicated by pneumonia and during the acute period of ischemic stroke: Similarities and differences
|
№5 / 2023
|
|
Semenova T.N., Grigoryeva V.N., Zanozina O.V., Sukhanov S.A.
Cognitive disorders in patients with hypertonic cerebral microangiopathy associated with type 2 diabetes mellitus and COVID-19
|
№5 / 2023
|
|
Mashin V.V., Belova L.A., Dudikov E.M., Slesareva E.V., Dolgova D.R., Nikishin K.E., Lyalchenko Yu.A.
Damage of nervous system in COVID-19: Neuropsychological syndromes, histological data
|
№5 / 2023
|
|
|
№3 (приложение) / 2023
|
|
Zakharov V.V., Ostroumova O.D., Kochetkov A.I., Klepikova M.V., Fedin A.I.
International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® FORTE 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension
|
№1 / 2023
|
|
Kamchatnov P.R., Cheremin R.A., Skipetrova L.A., Chugunov A.V.
Cognitive disorders of vascular genesis in the practice of a therapist
|
№9 / 2022
|
|
Bogolepova A.N., Osinovskaya N.A.
Asthenic disorders in the context of COVID-19 pandemic
|
№9 / 2022
|
|
Koltsov I.A., Shchukin I.A., Chubykin V.I., Fidler M.S.
Neuroinflammation and thromboinflammation in cerebrovascular disease and vascular cognitive impairment
|
№9 / 2022
|
Русский
